Autolus Therapeutics plc ADR (NASDAQ: AUTL) is -5.96% lower on its value in year-to-date trading and has touched a low of $2.07 and a high of $7.37 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The AUTL stock was last observed hovering at around $2.20 in the last trading session, with the day’s gains setting it 0.01%.
Currently trading at $2.21, the stock is -4.95% and -13.94% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.11 million and changing 0.45% at the moment leaves the stock -39.53% off its SMA200. AUTL registered -62.29% loss for a year compared to 6-month loss of -52.88%. The firm has a 50-day simple moving average (SMA 50) of $2.5679 and a 200-day simple moving average (SMA200) of $3.65445.
The stock witnessed a 0.00% gain in the last 1 month and extending the period to 3 months gives it a -49.08%, and is -6.75% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.77% over the week and 6.31% over the month.
Autolus Therapeutics plc ADR (AUTL) has around 463 employees, a market worth around $588.13M and $10.09M in sales. Profit margin for the company is -2677.90%. Distance from 52-week low is 6.76% and -70.01% from its 52-week high. The company has generated returns on investments over the last 12 months (-34.89%).
with sales reaching $2.98M over the same period.The EPS is expected to grow by 24.89% this year, but quarterly earnings will post 920.38% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
Autolus Therapeutics plc ADR (AUTL) Top Institutional Holders
The shares outstanding are 266.12M, and float is at 236.67M with Short Float at 3.54%.
The top institutional shareholder in the company is SYNCONA PORTFOLIO LTD with over 21.35 million shares valued at $74.29 million. The investor’s holdings represent 9.6083% of the AUTL Shares outstanding. As of 2024-06-30, the second largest holder is BLACKSTONE INC. with 20.49 million shares valued at $71.29 million to account for 9.2207 of the shares outstanding. The other top investors are WELLINGTON MANAGEMENT GROUP LLP which holds 17.89 million shares representing 8.0523% and valued at over $62.26 million, while DEEP TRACK CAPITAL, LP holds 6.8741 of the shares totaling 15.27 million with a market value of $53.15 million.
Autolus Therapeutics plc ADR (AUTL) Insider Activity
#####
